Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trial

Abstract

Registered in the Chinese Clinical Trial Register (ChiCTR2100042141).

Affiliated Institutions

• Xinxiang Central Hospital CN
• National Medical Products Administration CN
• First People's Hospital of Yunnan Province CN
• Kelun Group (China) CN
• First Affiliated Hospital of Bengbu Medical College CN
• West China Hospital of Sichuan University CN
• Affiliated Hospital of Xuzhou Medical College CN
• First Hospital of Jilin University CN
• First Hospital of China Medical University CN
• Jiangxi Provincial People's Hospital CN
• Liaoning University of Traditional Chinese Medicine CN
• Xiangyang Central Hospital CN
• Affiliated Hospital of Liaoning University of Traditional Chinese Medicine CN
• First Hospital of Shanxi Medical University CN
• Shandong Provincial Hospital CN
• First Affiliated Hospital of Soochow University CN
• The People's Hospital of Guangxi Zhuang Autonomous Region CN
• Qiqihar Medical University CN
• Qilu Hospital of Shandong University CN
• Soochow University CN
• Tianjin Medical University General Hospital CN
• First Affiliated Hospital of Chengdu Medical College CN
• Affiliated Hospital of North Sichuan Medical College CN
• Liuzhou General Hospital CN
• Sichuan University CN

Related Publications